Video

Uranimals: Episode 1

Author(s):

Urology Times staff

Current Time 0:00
Duration 0:00
Loaded: 0%
Stream Type LIVE
Remaining Time 0:00
 
1x
    • Chapters
    • descriptions off, selected
    • captions off, selected

      Welcome to the first installment of Uranimals, a video series featuring urologists and their pets brought to you by Urology Times. From a dog model to a whole farm of animals, the inaugural episode has an amazing lineup. Watch Drs. Amy Pearlman, Stacy Loeb, Michael Cookson, and Casey Dauw introduce you to their furry (and feathered!) friends.

      Related Videos
      Doctor consulting patient | Image Credit: © Liudmila Dutko - stock.adobe.com
      Strategies to bridge gender disparities in AAS and citations in the oncology literature
      Shot of a doctor showing a patient some information on a digital tablet | Image Credit | © bongkarn - stock.adobe.com
      OnabotA for OAB: Enhancing comfort and ensuring adherence
      Jad Chahoud, MD, on first-line zanzalintinib plus nivolumab for advanced ccRCC
      Jad Chahoud, MD, on first-line zanzalintinib plus nivolumab for advanced ccRCC
      Stacy Loeb, MD, MSc, PhD (Hon), answers a question during a Zoom video interview
      Stacy Loeb, MD, MSc, PhD (Hon), discusses the nuances of prostate cancer screening
      Maria Uloko, MD, on the need for better education on female sexual dysfunction
      Maria Uloko, MD, on the need for better education on female sexual dysfunction
      Dean Elterman, MD, on the shift toward personalized care in BPH
      Dean Elterman, MD, on the shift toward personalized care in BPH
      Jad Chahoud, MD, on the phase 1b STELLAR-002 trial in ccRCC
      Jad Chahoud, MD, on the phase 1b STELLAR-002 trial in ccRCC
      Fred Saad, MD, FRCS, discusses clinical impact of darolutamide approval in mCSPC
      Fred Saad, MD, FRCS, discusses clinical impact of darolutamide approval in mCSPC
      Ryan Hankins, MD, on rectal spacer utilization and erectile dysfunction
      Ryan Hankins, MD, on rectal spacer utilization and erectile dysfunction
      Jens Bedke, MD, on efficacy of EV plus pembrolizumab across subgroups in la/mUC
      Jens Bedke, MD, on efficacy of EV plus pembrolizumab across subgroups in la/mUC
      Related Content
      Prostate Gland - (BPH) Benign Prostatic Hyperplasia | Image Credit: © Judith - stock.adobe.com
      December 26th 2024

      Top 10 BPH articles and videos of 2024

      Benjamin P. Saylor
      As the year comes to a close, we revisit some of this year’s top content on benign prostatic hyperplasia.
      Crystal light - stock.adobe.com
      March 4th 2022

      Efficacy of batiraxcept/cabozantinib combo in clear cell RCC: Updated results

      Janelle Hart
      Dr. Lacouture on managing dermatological adverse events with apalutamide in prostate cancer
      February 7th 2022

      Dr. Lacouture on managing dermatological adverse events with apalutamide in prostate cancer

      Janelle Hart
      To investigate the severity and prevalence of dermatologic adverse events associated with apalutamide, Mario E. Lacouture, MD, and investigators conducted a study that will help to manage and counsel patients with prostate cancer in the future, especially with the expanded approval of apalutamide in this space.
      How appropriate use criteria for PSMA-PET imaging optimize patient care
      February 2nd 2022

      How appropriate use criteria for PSMA-PET imaging optimize patient care

      Janelle Hart
      In a recent interview, Hossein Jadvar, MD, PhD, discussed what the appropriate use criteria consist of for prostate-specific membrane antigen (PSMA)-PET imaging, and why these criteria are vital in ensuring the individualized care of patients.
      Dr. Chee summarizes latest Optilume data in patients with urethral strictures
      November 9th 2021

      Dr. Chee summarizes latest Optilume data in patients with urethral strictures

      Urology Times staff
      "Certainly, the Optilume drug-coated balloon appears to be safe and effective in roughly two-thirds of patients at 3 years," said Justin Chee, MD.
      Dr. Declan G. Murphy describes the background of PSMA PET/CT in prostate cancer
      December 16th 2020

      Dr. Declan G. Murphy describes the background of PSMA PET/CT in prostate cancer

      Urology Times staff
      Murphy shares the backstory of how PSMA PET/CT imaging has emerged as a major advancement in the prostate cancer armamentarium.
      © 2025 MJH Life Sciences

      All rights reserved.